The Parp Inhibitor market comprises drugs that hinder the activity of Poly (ADP-ribose) polymerase, or PARP for short. PARP is an enzyme involved in DNA repair. PARP inhibitors are mainly used for the treatment of cancers with defects in homologous recombination repair (HRR) genes like BRCA1 and BRCA2. https://articlescad.com/parp-inhibitor-market-is-estimated-to-witness-high-growth-owing-to-technological-advancements-in-can-219639.html